Emergent BioSolutions Inc. has agreed to pay $40 million to settle a lawsuit brought by shareholders who had accused it of ...

Common medicines used to treat conditions including heartburn, reflux, indigestion and stomach ulcers may be the subject of a ...

India's confirmed mpox case from an older virus strain, MBX Biosciences' US IPO plans, AstraZeneca's trial results of a lung ...

The GSK share price is nearly 10% off its 52-week high, and this Fool is keen to take a closer look. Could it be a stock for ...

After stints at AstraZeneca and Johnson & Johnson ... on top of the company paying a combined $204 million to settle individual lawsuits with four other states. Around the same time, the company ...

After a landmark $US425 million settlement in the United States, the drugs are being investigated in Australia over alleged ...

Biogen has finalised a $900 million payment to settle a whistleblower lawsuit claiming that it ... A machine-learning tool developed by AstraZeneca and trained on UK Biobank health record data ...

An AstraZeneca Plc unit settled a federal patent-infringement lawsuit with a Samsung Biologics Co. subsidiary after failing to block its biosimilar version of the $500,000-per-patient drug Soliris.

The eight sets of case studies showcased here feature examples of the most innovative work and legal service that lawyers ...

AstraZeneca unit and Samsung Bioepis resolve their patent dispute over a biosimilar | Settlement follows FDA approval for the ...